Alnylam Pharmaceuticals, Inc. (LON:0HD2)

Alnylam Pharmaceuticals Ratios and Metrics

Market cap in millions GBP. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 27, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	43,887	24,243	18,858	24,266	14,979	11,060
Market Cap Growth	27.60%	28.56%	-22.29%	62.00%	35.43%	14.08%
Enterprise Value	43,800	24,200	19,060	24,537	14,677	10,722
Last Close Price	335.18	190.55	151.59	191.34	119.22	99.03
PS Ratio	24.42	13.50	13.14	28.18	24.02	30.64
PB Ratio	239.94	452.40	-108.87	-184.79	34.48	14.86
P/TBV Ratio	239.94	452.40	-	-	34.48	14.86
P/FCF Ratio	-	-	572.67	-	-	-
P/OCF Ratio	-	-	230.62	-	-	-
EV/Sales Ratio	24.03	13.48	13.28	28.50	23.54	29.70
EV/FCF Ratio	-1152.05	-	578.81	-	-	-
Debt / Equity Ratio	10.93	40.89	-12.16	-16.51	3.72	1.57
Debt / FCF Ratio	-	-	63.96	-	-	-
Asset Turnover	0.57	0.56	0.50	0.29	0.24	0.17
Inventory Turnover	5.17	3.86	2.85	1.57	1.74	1.19
Quick Ratio	2.63	2.61	2.86	3.17	3.79	4.23
Current Ratio	2.80	2.78	3.08	3.51	4.04	4.47
Return on Equity (ROE)	-257.82%	-	-	-526.14%	-106.31%	-69.92%
Return on Assets (ROA)	-2.63%	-2.74%	-4.78%	-13.65%	-12.56%	-17.85%
Return on Capital (ROIC)	-3.95%	-4.19%	-7.17%	-18.77%	-16.46%	-23.80%
Earnings Yield	-0.53%	-0.92%	-1.83%	-3.87%	-4.21%	-5.68%
FCF Yield	-0.09%	-0.14%	0.18%	-2.10%	-3.54%	-4.54%
Buyback Yield / Dilution	-2.84%	-2.20%	-2.64%	-2.73%	-3.01%	-5.24%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.